Skip to main content
SpringerLink
Log in
Book cover

Liver Anesthesiology and Critical Care Medicine pp 257–267Cite as

Perioperative Considerations for Transplantation in Acute Liver Failure

  • Chapter
  • First Online:

  • 1275 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hoofnagle JH, Carithers RL, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology. 1995;21:240–52.

    CAS  PubMed  Google Scholar 

  2. Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol. 2004;40(2):192–7.

    Article  PubMed  Google Scholar 

  3. Stravitz RT. Critical management decisions in patients with acute liver failure. Chest. 2008;134(5):1092–102.

    Article  PubMed  Google Scholar 

  4. Marudanayagam R, Shanmugam V, Gunson B, Mirza DF, Mayer D, Buckels J, et al. Aetiology and outcome of acute liver failure. HPB (Oxford). 2009;11(5):429–34.

    Article  Google Scholar 

  5. Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2014;370(12):1170–1.

    Article  CAS  PubMed  Google Scholar 

  6. Farmer DG, Anselmo DM, Ghobrial RM, Yersiz H, McDiarmid SV, Cao C, et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg. 2003;237(5):666–75. discussion 675–6.

    PubMed  PubMed Central  Google Scholar 

  7. Germani G, Theocharidou E, Adam R, Karam V, Wendon J, O’Grady J, et al. Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. J Hepatol. 2012;57(2):288–96.

    Article  PubMed  Google Scholar 

  8. Bernal W, Lee WM, Wendon J, Larsen FS, Williams R. Acute liver failure: a curable disease by 2024? J Hepatol. 2015;62(1 Suppl):S112–20.

    Article  PubMed  Google Scholar 

  9. O’Grady J. Timing and benefit of liver transplantation in acute liver failure. J Hepatol. 2014;60(3):663–70.

    Article  PubMed  Google Scholar 

  10. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA. 2003;289(2):217–22.

    Article  PubMed  Google Scholar 

  11. Husberg BS, Goldstein RM, Klintmalm GB, Gonwa T, Ramsay M, Cofer J, et al. A totally failing liver may be more harmful than no liver at all: three cases of total hepatic devascularization in preparation for emergency liver transplantation. Transplant Proc. 1991;23(1 Pt 2):1533–5.

    CAS  PubMed  Google Scholar 

  12. Ringe B, Pichlmayr R. Total hepatectomy and liver transplantation: a life-saving procedure in patients with severe hepatic trauma. Br J Surg. 1995;82(6):837–9.

    Article  CAS  PubMed  Google Scholar 

  13. Ejlersen E, Larsen FS, Pott F, Gyrtrup HJ, Kirkegaard P, Secher NH. Hepatectomy corrects cerebral hyperperfusion in fulminant hepatic failure. Transplant Proc. 1994;26(3):1794–5.

    CAS  PubMed  Google Scholar 

  14. Rozga J, Podesta L, LePage E, Hoffman A, Morsiani E, Sher L, et al. Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet. 1993;342(8876):898–9.

    Article  CAS  PubMed  Google Scholar 

  15. Bustamante M, Castroagudín JF, Gonzalez-Quintela A, Martinez J, Segade FR, Fernández A, et al. Intensive care during prolonged anhepatic state after total hepatectomy and porto-caval shunt (two-stage procedure) in surgical complications of liver transplantation. Hepatogastroenterology. 2000;47(35):1343–6.

    CAS  PubMed  Google Scholar 

  16. Domínguez Fernández E, Lange K, Lange R, Eigler FW. Relevance of two-stage total hepatectomy and liver transplantation in acute liver failure and severe liver trauma. Transpl Int. 2001;14(3):184–90.

    Article  PubMed  Google Scholar 

  17. Cheema SP, Hughes A, Webster NR, Bellamy MC. Cardiac function during orthotopic liver transplantation with venovenous bypass. Anaesthesia. 1995;50(9):776–8.

    Article  CAS  PubMed  Google Scholar 

  18. Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int. 2005;47(1–2):78–83.

    Article  CAS  PubMed  Google Scholar 

  19. Ardizzone G, Arrigo A, Panaro F, Ornis S, Colombi R, Distefano S, et al. Cerebral hemodynamic and metabolic changes in patients with fulminant hepatic failure during liver transplantation. TPS. 2004;36(10):3060–4.

    CAS  Google Scholar 

  20. Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am. 1993;22(2):257–69.

    CAS  PubMed  Google Scholar 

  21. Detry O, Arkadopoulos N, Ting P, Kahaku E, Margulies J, Arnaout W, et al. Intracranial pressure during liver transplantation for fulminant hepatic failure. Transplantation. 1999;67(5):767–70.

    Article  CAS  PubMed  Google Scholar 

  22. Jalan R, Olde Damink SWM, Deutz NEP, Davies NA, Garden OJ, Madhavan KK, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75(12):2034–9.

    Article  PubMed  Google Scholar 

  23. Jalan R, Pollok A, Shah SHA, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol. 2002;37(4):536–8.

    Article  CAS  PubMed  Google Scholar 

  24. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology. 1992;16(1):1–7.

    Article  CAS  PubMed  Google Scholar 

  25. Dmello D, Cruz-Flores S, Matuschak GM. Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: a systematic review. Intensive Care Med. 2010;36(2):210–3.

    Article  PubMed  Google Scholar 

  26. Detry O, De Roover A, Honore P, Meurisse M. Brain edema and intracranial hypertension in fulminant hepatic failure: pathophysiology and management. World J Gastroenterol. 2006;12(46):7405–12.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Blei AT. Monitoring cerebral blood flow: a useful clinical tool in acute liver failure? Liver Transpl. 2005;11(11):1320–2.

    Article  PubMed  Google Scholar 

  28. Noun R, Zante E, Sauvanet A, Durand F, Bernuau J, Belghiti J. Liver devascularisation improves the hyperkinetic syndrome in patients with fulminant and subfulminant hepatic failure. Transplant Proc. 1995;27(1):1256–7.

    CAS  PubMed  Google Scholar 

  29. Filho JAR, Machado MAC, Nani RS, Rocha JPS, Figueira ERR, Bacchella T, et al. Hypertonic saline solution increases cerebral perfusion pressure during clinical orthotopic liver transplantation for fulminant hepatic failure: preliminary results. Clinics (Sao Paulo). 2006;61(3):231–8.

    Article  Google Scholar 

  30. Kang YG, Martin DJ, Marquez J, Lewis JH, Bontempo FA, Shaw BW, et al. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg. 1985;64(9):888–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Massicotte L, Lenis S, Thibeault L, Sassine M-P, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl. 2005;12(1):117–23.

    Article  Google Scholar 

  32. Bolliger D, Szlam F, Molinaro RJ, Rahe-Meyer N, Levy JH, Tanaka KA. Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. Br J Anaesth. 2009;102(6):793–9.

    Article  CAS  PubMed  Google Scholar 

  33. Wikkelsø A, Lunde J, Johansen M, Stensballe J, Wetterslev J, Møller AM, et al. Fibrinogen concentrate in bleeding patients. Cochrane Database Syst Rev. 2013;8:CD008864.

    Google Scholar 

  34. Sabate A, Gutierrez R, Beltran J, Mellado P, Blasi A, Acosta F, et al. Impact of pre-emptive fibrinogen concentrate on transfusion requirements in liver transplantation: a multicenter, randomized, double-blind, placebo-controlled trial. Am J Transplant. 2016;16:2421–9.

    Article  CAS  PubMed  Google Scholar 

  35. Clevenger B, Mallett SV. Transfusion and coagulation management in liver transplantation. World J Gastroenterol. 2014;20(20):6146–58.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus. 2010;8(3):149–54.

    PubMed  PubMed Central  Google Scholar 

  37. Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, et al. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg. 2013;13:22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl. 2003;9(2):138–43.

    Article  PubMed  Google Scholar 

  39. Lodge JPA, Jonas S, Jones RM, Olausson M, Mir-Pallardo J, Soefelt S, et al. Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation. Liver Transpl. 2005;11(8):973–9.

    Article  PubMed  Google Scholar 

  40. Surudo T, Wojcicki M, Milkiewicz P, Czuprynska M, Lubikowski J, Jarosz K, et al. Rapid correction of prothrombin time after low-dose recombinant factor VIIA in patients undergoing orthotopic liver transplantation. Transplant Proc. 2003;35(6):2323–5.

    Article  CAS  PubMed  Google Scholar 

  41. Hendriks HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study. Transplantation. 2001;71(3):402–5.

    Article  CAS  PubMed  Google Scholar 

  42. Pavese P, Bonadona A, Beaubien J, Labrecque P, Pernod G, Letoublon C, et al. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth. 2005;52(1):26–9.

    Article  PubMed  Google Scholar 

  43. Chavez-Tapia NC, Alfaro-Lara R, Tellez-Avila F, Barrientos-Gutiérrez T, González-Chon O, Mendez-Sanchez N, et al. Prophylactic activated recombinant factor VII in liver resection and liver transplantation: systematic review and meta-analysis. PLoS One. 2011;6(7):e22581.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, et al. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med. 2011;154(8):529–40.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Levi M, Levy JH, Andersen HF, Truloff D. Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med. 2010;363(19):1791–800.

    Article  CAS  PubMed  Google Scholar 

  46. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30(6):270–382.

    Article  PubMed  Google Scholar 

  47. Blasi A, Hessheimer AJ, Beltrán J, Pereira A, Fernández J, Balust J, et al. Liver transplant from unexpected donation after circulatory determination of death donors: a challenge in perioperative management. Am J Transplant. 2016;16(6):1901–8.

    Article  CAS  PubMed  Google Scholar 

  48. Dzik WH, Arkin CF, Jenkins RL, Stump DC. Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood. 1988;71(4):1090–5.

    CAS  PubMed  Google Scholar 

  49. Porte RJ, Bontempo FA, Knot EA, Lewis JH, Kang YG, Starzl TE. Tissue-type-plasminogen-activator-associated fibrinolysis in orthotopic liver transplantation. TPS. 1989;21(3):3542.

    CAS  Google Scholar 

  50. Porte RJ, Knot EA, Bontempo FA. Hemostasis in liver transplantation. Gastroenterology. 1989;97(2):488–501.

    Article  CAS  PubMed  Google Scholar 

  51. Lisman T, Leebeek FWG, Meijer K, Van Der Meer J, Nieuwenhuis HK, De Groot PG. Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation. Hepatology. 2002;35(3):616–21.

    Article  PubMed  Google Scholar 

  52. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358(22):2319–31.

    Article  CAS  PubMed  Google Scholar 

  53. Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. The Lancet. 2000;355(9212):1303–9.

    Article  CAS  Google Scholar 

  54. LaMattina JC, Kelly PJ, Hanish SI, Ottmann SE, Powell JM, Hutson WR, et al. Intraoperative continuous veno-venous hemofiltration facilitates surgery in liver transplant patients with acute renal failure. Transplant Proc. 2015;47(6):1901–4.

    Article  CAS  PubMed  Google Scholar 

  55. Douthitt L, Bezinover D, Uemura T, Kadry Z, Shah RA, Ghahramani N, et al. Perioperative use of continuous renal replacement therapy for orthotopic liver transplantation. Transplant Proc. 2012;44(5):1314–7.

    Article  CAS  PubMed  Google Scholar 

  56. Sedra AH, Strum E. The role of intraoperative hemodialysis in liver transplant patients. Curr Opin Organ Transplant. 2011;16(3):323–5.

    Article  PubMed  Google Scholar 

  57. Tobias MD, Jobes CS, Aukburg SJ. Hemofiltration in parallel to the venovenous bypass circuit for oliguric hypervolemia during liver transplantation. Anesthesiology. 1999;90(3):909–11.

    Article  CAS  PubMed  Google Scholar 

  58. Blackwell MM, Chavin KD, Sistino JJ. Perioperative perfusion strategies for optimal fluid management in liver transplant recipients with renal insufficiency. Perfusion. 2003;18(1):55–60.

    Article  CAS  PubMed  Google Scholar 

  59. Davenport A. Continuous renal replacement therapies in patients with liver disease. Semin Dial. 2009;22(2):169–72.

    Article  PubMed  Google Scholar 

  60. Srinivas Reddy M, Wilson C, Torpey N, Manas DM. ABO incompatible liver transplantation: a case of immediate need. Transpl Int. 2007;20(10):904–5.

    Article  PubMed  Google Scholar 

  61. Kluger MD, Guarrera JV, Olsen SK, Brown RS, Emond JC, Cherqui D. Safety of blood group A2-to-O liver transplantation: an analysis of the United Network of Organ Sharing database. Transplantation. 2012;94(5):526–31.

    Article  PubMed  Google Scholar 

  62. Shen T, Lin B-Y, Jia J-J, Wang Z-Y, Wang L, Ling Q, et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. Hepatobiliary Pancreat Dis Int. 2014;13(4):395–401.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Perioperative Medicine and Critical Care, Freeman Hospital, Newcastle Upon Tyne, UK

    C. P. Snowden B Med Sci (Hons), FRCA, MD, D. M. Cressey BSc (Hons), MBBS, FRCA & J. Prentis MBBS, FRCA

Authors
  1. C. P. Snowden B Med Sci (Hons), FRCA, MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. M. Cressey BSc (Hons), MBBS, FRCA
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Prentis MBBS, FRCA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. P. Snowden B Med Sci (Hons), FRCA, MD .

Editor information

Editors and Affiliations

  1. Department of Anesthesiology, Columbia University Medical Center, New York, New York, USA

    Gebhard Wagener

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Snowden, C.P., Cressey, D.M., Prentis, J. (2018). Perioperative Considerations for Transplantation in Acute Liver Failure. In: Wagener, G. (eds) Liver Anesthesiology and Critical Care Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-64298-7_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64298-7_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64297-0

  • Online ISBN: 978-3-319-64298-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation